Modified Ridge Splitting Technique Using Autogenous Bone Blocks (MRS)
Launched by SEMMELWEIS UNIVERSITY · Aug 10, 2021
Trial Information
Current as of June 28, 2025
Unknown status
Keywords
ClinConnect Summary
Patients were required to rinse with a 0.2% chlorhexidine solution for 1 min before surgery. Under local anesthesia, a full-thickness flap was raised from a crestal incision with a mesial releasing incision to access the alveolar ridge and the retromolar area. A midcrestal osteotomy was preformed, leaving a safety zone of at least 2 mm from the adjacent tooth. Two vertical releasing osteotomies were performed at the mesial and distal ends of the mid-crestal osteotomy. Apically, the vertical osteotomies were connected horizontally with a superficial corticotomy. Osteotomies and corticotomies...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Mandibular ridge width at least 3 mm;
- • Ridge height at least 11 mm;
- • Spongiosa between the two cortical plates at least 1 mm
- Exclusion Criteria:
- • History of uncontrolled medical disorders;
- • History of systemic diseases or medication that alter bone metabolism;
- • Poor oral hygiene;
- • Smoking
About Semmelweis University
Semmelweis University, located in Budapest, Hungary, is a prestigious institution renowned for its commitment to advancing medical education, research, and healthcare innovation. As a prominent clinical trial sponsor, the university leverages its extensive expertise in various medical fields to conduct rigorous clinical studies aimed at improving patient outcomes and enhancing therapeutic strategies. With a focus on ethical standards and scientific excellence, Semmelweis University collaborates with a network of healthcare professionals and researchers to translate groundbreaking discoveries into practical applications, ultimately contributing to the global advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Budapest, , Hungary
Patients applied
Trial Officials
Márton Kivovics, Ph.D
Study Director
Semmelweis University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials